J. Nobes

发表

State-of-the-art: prostate LDR brachytherapy

R. Laing, S. Langley, S. Voulgaris, 2008, Prostate Cancer and Prostatic Diseases.

RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases – results and lessons learnt

S. Love, C. Roberts, M. Middleton, 2016, British Journal of Cancer.

Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial.

J. Larkin, A. Melcher, K. Harrington, 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients

J. Larkin, R. Plummer, A. Dalgleish, 2015, Melanoma research.

Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study

V. Sondak, R. Scolyer, S. Lo, 2022, Annals of Surgical Oncology.

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

P. Dziewulski, M. Gore, M. Highley, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Commentary on the British Association of Dermatologists UK basal cell carcinoma guidelines 2021: all together now …

M. Moncrieff, J. Nobes, 2021, The British journal of dermatology.

Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis

Rebecca C Fitzgerald, Carlos Caldas, Arusha Oloumi, 2014, Nature Genetics.

Metabolic syndrome and prostate cancer: a review.

R. Laing, S. Langley, J. Nobes, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.

M. Gore, P. Nathan, P. Lorigan, 2014, The Lancet. Oncology.

A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma

J. Garioch, M. Moncrieff, A. Paterson, 2016, British Journal of Cancer.

Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2)

James X. Sun, Lesly A. Dossett, V. Sondak, 2021, Cancer.

UKMCC-01: A phase II study of pazopanib (PAZ) in metastatic Merkel cell carcinoma.

J. Larkin, P. Nathan, P. Lorigan, 2016 .

Prostate Cancer and the Metabolic Syndrome

S. Langley, J. Nobes, 2013 .

Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease

V. Sondak, R. Scolyer, I. Johansson, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients

J. Garioch, M. Moncrieff, M. Heaton, 2022, Annals of Surgical Oncology.

Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection

James X. Sun, Lesly A. Dossett, T. Hieken, 2022, Journal for ImmunoTherapy of Cancer.

A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy

R. Laing, S. Langley, D. Russell-Jones, 2012, BJU international.

Machine-learning algorithm to predict multidisciplinary team treatment recommendations in the management of basal cell carcinoma

J. Garioch, M. Moncrieff, N. Hamnett, 2021, British Journal of Cancer.

Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience

S. Langley, J. Money-Kyrle, S. Khaksar, 2009, Prostate Cancer and Prostatic Diseases.

International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers

James X. Sun, Lesly A. Dossett, V. Sondak, 2022, Annals of surgery.

Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial

T. Ahmed, S. Lo, A. Hong, 2023, Clinical and translational radiation oncology.

Long‐term toxicity and quality of life up to 10 years after low‐dose rate brachytherapy for prostate cancer

Stephen E M Langley, R. Laing, S. Langley, 2012, BJU international.

Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: Preplanned interim results for the AVAST-M trial.

M. Gore, P. Nathan, P. Lorigan, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.

R. Laing, S. Langley, M. Cunningham, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Royal College of Radiologists' audit of prostate brachytherapy in the year 2012.

R. Laing, I. Locke, K. Drinkwater, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

1105PVEMURAFENIB FOR BRAF V600 MUTATED ADVANCED MELANOMA: RESULTS OF TREATMENT BEYOND PROGRESSION.

Y. S. Kim, Su Jin Lee, J. Utikal, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Ipilimumab in the real world: The UK expanded access programme (EAP) experience in advanced melanoma.

J. Larkin, R. Plummer, A. Dalgleish, 2013 .

Whole-genome sequencing provides new insights into the clonal architecture of Barrett’s esophagus and esophageal adenocarcinoma

S. Tavaré, D. Bentley, R. K. Cheetham, 2015, Nature Genetics.

The value of Day 1 imaging following LDR prostate brachytherapy.

R. Laing, S. Langley, J. Nobes, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic

K. Fife, A. Challapalli, A. Sykes, 2020, Clinics in oncology.

Small-Cell Carcinoma of the Prostate – Challenges of Diagnosis and Treatment: A Next of Kin and Physician Perspective Piece

J. Nobes, P. Muehlschlegel, Kenrick K H Ng, 2023, Oncology and Therapy.

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

M. Gore, A. Dalgleish, P. Nathan, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Use of metformin and lifestyle intervention to prevent ADT-related metabolic syndrome in prostate cancer.

R. Laing, S. Langley, J. Nobes, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.